PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
75.63%
Net income growth above 1.5x AVGO's 25.66%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
1.70%
Less D&A growth vs. AVGO's 9.52%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
184.35%
Lower deferred tax growth vs. AVGO's 500.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
2.52%
Less SBC growth vs. AVGO's 11.11%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-327.22%
Both reduce yoy usage, with AVGO at -556.25%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
100.62%
AR growth while AVGO is negative at -760.00%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
6.94%
Inventory growth of 6.94% while AVGO is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-151.50%
Both negative yoy AP, with AVGO at -69.44%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-838.58%
Both reduce yoy usage, with AVGO at -520.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-100.06%
Both negative yoy, with AVGO at -500.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-9.66%
Both yoy CFO lines are negative, with AVGO at -28.27%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
27.86%
Some CapEx rise while AVGO is negative at -38.30%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-11.12%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-16.47%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
172.82%
Growth well above AVGO's 196.43%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-115.81%
Both yoy lines negative, with AVGO at -421.43%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-3.02%
We cut debt repayment yoy while AVGO is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.